In a significant 2025–2026 strategic move, Upside shifted its immediate commercial focus toward hybrid products (e.g., shredded chicken) that blend cultivated animal cells with plant-based proteins, making them easier and more cost-effective to produce at scale. The company is currently a leader in the legal fight against state-level bans on lab-grown meat, and as of early 2026, they are actively challenging a ban in Florida.
Cyborg Score Rationale
Upside Foods holds significant first-mover advantages and regulatory validation, but faces the complex scaling and commercialization phase. Recent strategic pivots to hybrid products and regulatory challenges temper near-term upside, though long-term market potential remains substantial.
Top Insights
Upside Foods founded the field of cultured meat in 2015.
Upside was the first company in the U.S. to receive a 'green light' from the FDA in 2022.
As of March 2026, Upside is navigating the difficult 'scaling' phase; in 2025–2026, it shifted toward hybrid products blending cultivated cells with plant-based proteins for cost-effective production.
The company is actively engaged in regulatory defense, challenging state-level cultivated meat bans as of early 2026.
Named Competitors
Beyond Meat — Plant-based meat alternative
Impossible Foods — Plant-based burger and meat substitute
Tyson Foods — Traditional meat and poultry producer
Cargill — Diversified agricultural and food company